Electronic ISSN 2287-0237

VOLUME

MIDTERM RESULTS OF SURGICAL INTRAMYOCARDIAL IMPLANTATION OF AUTOLOGOUS ANGIOGENIC CELL PRECURSORS FOR CARDIOMYOPATHY

FEBRUARY 2017 - VOL.13 | ORIGINAL ARTICLE
  1. Wexler RK, Elton T, Pleister A, Feldman D. Cardiomyopathy: an overview. Am Fam Physician 2009;79:778-84.
  2. Hellermann JP, Jacobsen SJ, Redfeld MM, et al. Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail 2005;7:119-25.
  3. Menasche P, Alferi O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: frst randomized placebo-controlled study of myoblast transplantation.Circulation 2008;117:1189-200.
  4. Hagege AA, Marolleau JP, Vilquin JT, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the frst phase I cohort of patients.Circulation 2006;114:I108-13
  5. Porat Y, Porozov S, Belkin D, et al. Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages.Br J Haematol 2006;135:703-14.
  6. Sun Z, Wu J, Fujii H, et al. Human angiogenic cell precursors restore function in the infarcted rat heart: a comparison of cell delivery routes.Eur J Heart Fail 2008;10:525-33.
  7. Arom KV, Ruengsakulrach P, Jotisakulratana V. Intramyocardial angiogenic cell precursor injection for cardiomyopathy.
    Asian Cardiovasc Thorac Ann 2008;16:143-8.
  8. Ermis C, Zadeii G, Zhu AX, et al. Improved survival of cardiac transplantation candidates with implantable cardioverter defbrillator therapy: role of beta-blocker or amiodarone treatment. J Cardiovasc Electrophysiol 2003;14:578-83.
  9. Williams JA, Patel ND, Nwakanma LU, et al. Outcomes following surgical ventricular restoration in elderly patients with congestive heart failure.Am J Geriatr Cardiol2007;16:67-75.
  10. Shuhaiber J, Hur K, Gibbons R. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?J Card Surg 2009;24:250-5.
  11. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation 2010;122:173-83.
  12. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.Mol Cell Endocrinol 2004;217:53-8.
  13. Ather S, Peterson LE, Divakaran VG, et al. Digoxin treatment in heart failure - Unveiling risk by cluster analysis of DIG data.Int J Cardiol 2011;150:264-9.
  14. Thekkudan J, Rogers CA, Thomas HL, et al. Trends in adult heart transplantation: a national survey from the United Kingdom Cardiothoracic Transplant Audit 1995-2007.Eur J Cardiothorac Surg 2010;37:80-6.
  15. Marelli D, Kobashigawa J, Hamilton MA, et al. Long-term outcomes of heart transplantation in older recipients. J Heart Lung Transplant 2008;27:830-4.
  16.  Vrtovec B, Poglajen G, Sever M, et al. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy.J Card Fail 2011;17:272-81.
  17. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: fnal one-year results of the TOPCAREAMI Trial.J Am Coll Cardiol 2004;44:1690-9.
  18. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.Eur Heart J 2009;30:2978-84.
  19. Stamm C, Kleine HD, Choi YH, et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and effcacy studies.J Thorac Cardiovasc Surg 2007;133:717-25.
  20. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrowderived cells for cardiac repair: a systematic review and meta- nalysis.Arch Intern Med 2007;167:989-97.
  21. Assmus B, Rolf A, Erbs S, et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.Circ Heart Fail 2010;3:89-96.
  22. Akar AR, Durdu S, Arat M, et al. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Eur J Cardiothorac Surg 2009;36:633-43.
  23. Yousef M, Schannwell CM, Kostering M, et al. The BALANCE Study: clinical beneft and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 2009;53:2262-9.
  24. Arom K, Ruengsakulrach P, Jotisakulratana V. Effcacy of Intramyocardial Injection of Angiogenic Cell Precursors for Ischemic Cardiomyopathy: A Case Match Study.Innovations 2008;3:38-45. 25. Arom KV, Ruengsakulrach P, Belkin M, et al. Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathy.Asian Cardiovasc Thorac Ann 2009;17:382-8.
SEARCH VOLUME & NUMBER
GO
RECENT VOLUME & NUMBER